Worldwide study on field trials of biotechnological crops: new promises but old policy hurdles
2024

Worldwide Study on Field Trials of Biotechnological Crops

Sample size: 187 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ricroch Agnès, Desachy Louie-David, Penfornis Mateo, Akin Melekşen, Kondić-Špika Ankica, Kuntz Marcel, Miladinović Dragana

Primary Institution: Laboratoire Institut Droit, Espaces et Technologies (IDEST), Faculté Jean Monnet, Université Paris-Saclay

Hypothesis

What are the current trends and regulatory challenges in field trials of biotechnological crops worldwide?

Conclusion

Field trials of biotech crops are crucial for commercialization, but regulatory hurdles vary significantly across countries.

Supporting Evidence

  • Field trials are essential for the commercialization of biotech crops.
  • Regulatory policies significantly influence the acceptance of field trials.
  • Only 41 out of 141 countries with biotech research are currently conducting field trials.

Takeaway

This study looks at how different countries are testing new biotech crops in fields and why some countries are more open to it than others.

Methodology

The study compiled data from a survey of 55 countries and intergovernmental databases regarding field trials of biotech crops.

Potential Biases

Potential bias due to reliance on self-reported data from researchers and varying levels of transparency in different countries.

Limitations

Data could not be obtained for some countries, limiting the comprehensiveness of the study.

Participant Demographics

Researchers from 55 countries involved in biotech plant research.

Digital Object Identifier (DOI)

10.3389/fpls.2024.1452767

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication